News
Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure. A ...
A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...
Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health ...
3 Analysis of the application of genomics large language model in the discovery of drug target gene code With the increasing demand for biological data mining in drug target discovery and new drug ...
Doctors and scientists in the US have done the impossible by healing a baby using customised gene-editing therapy, which involves rewriting faulty DNA. In a medical feat that has been hailed ...
An experimental gene editing therapy helped save a baby with CPS1 deficiency, marking a breakthrough in treating rare genetic disorders using CRISPR technology.
In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized treatments of rare diseases.
Have you heard of CRISPR? What about gene therapy. Does the ability to more easily change the blueprint of life mean we're on the path to repairing the broken bits in our genetic inheritance? Or ...
Learn to invest in the gene-editing arm of genomics and explore the field's most promising companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results